Summary
Discover the Perfect Assay Price Point to Remain Competitive
The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therapy monitoring). A selective list of therapeutic areas covered in this research include: autoimmune diseases, cancers (breast, colorectal, prostrate, lung, gastric, cervical, and ovarian), toxicology, cardiology, women’s health (vitamin D, prenatal, pregnancy and hormone), and infectious disease testing (TB, hepatitis A/B/C, cytomegalovirus). The base year used for analysis is 2015.
Table of contents
Executive Summary
Research Scope
Executive Summary
Research Objectives
Abbreviations
Autoimmune Diseases
Celiac Disease Specific LDT Assays
Chron's Disease Specific LDT Assays
Rheumatoid Arthritis Specific LDT Assays
Lupus Specific LDT Assays
LupusSpecific LDT Assays (continued)
IBD and IBS Specific LDT Assays
Biomarker Guidelines
Cardiology
Cardiac Disease Specific LDTs and FDA Assays
Oncology
Prostate Cancer Specific LDT Assays
Breast Cancer Specific LDT Assays
Colon Cancer Specific LDT and CLIA Waived Assays
Lung Cancer Specific LDT and FDA Assays
Gynecologic Cancers (Ovarian)Specific LDT and FDA Assays
Gynecologic Cancers (Cervical)Specific LDT and FDA Assays
Biomarker Guidelines
Gastric Cancer/GIST Specific LDT and FDA Assays
Other Areas
Women's Health Vitamin D Tests
Women's Health Prenatal Tests
Women's Health Pregnancy and Hormone Tests
Toxicology Popularly Ordered Tests
Infectious Diseases Popularly Ordered Genetic Tests
Infectious Diseases Popularly Ordered Tests
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Methodology
Our market research methodology is designed to provide the clients with comprehensive and accurate information
on various
industries and markets. It includes data collection, primary interviews, macro-economic factor analysis,
country-level data
analysis etc.
The data is gathered from a wide range of sources, including industry reports, government statistics, and
company financials.
This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary
interviews are conducted
with industry experts and key stakeholders to gather their insights and perspectives on the market. This
information is then
combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis
is also carried
out to understand the impact of external factors on the market. Finally, country-level data analysis is
performed to
understand the market dynamics in specific regions and countries.
Reportlinker's market research methodology is designed to provide clients with a clear understanding of the
market, its trends,
and its future potential.
Related Topics
Related Reports
-
Biologics Contract Manufacturing Market Research Report by Product, Platform, Therapeutic Area, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030
-
Injectable Drugs Market Research Report by Molecule Type, Drug Class, Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
-
Molecular Quality Controls Market Research Report by Product, Analyte Type, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030
+ See all
Related Reports
More Reports